NEW YORK, NY / ACCESS Newswire / May 6, 2025 / If you suffered a loss on your Ultra Clean Holdings, Inc. (NASDAQ:UCTT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ultra-clean-holdings-inc-lawsuit-submission-form?prid=147217&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 6, 2025 / If you suffered a loss on your Civitas Resources, Inc. (NYSE:CIVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/civitas-resources-lawsuit-submission-form?prid=147223&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of GoHealth, Inc. ("GoHealth, Inc.") (NASDAQ:GOCO) concerning possible violations of federal securities laws. The U.S. Department of Justice ("DOJ") announced on May 1, 2025, the filing of a False Claims Act complaint against several health insurance companies and insurance broker organizations, including GoHealth, "alleging that from 2016 through at least 2021, the defendant insurers paid hundreds of millions of dollars in illegal kickbacks to the defendant brokers in exchange for enrollments into the insurers' Medicare Advantage plans.

NEW YORK, NY / ACCESS Newswire / May 6, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=147218&wire=1 or contact Joseph E. Levi, Esq.

Lending platform Upstart Holdings' first quarter results saw loan originations nearly double from a year ago, driven in part by automated processes, while management pointed to strong credit metrics among the lending platform's borrowers. Platform originations were up 89%, the company said, to $2.1 billion.

Oil rose in the morning Asian session after the U.S. reached a truce with the Houthis in Yemen and said it would suspend its airstrikes there.

Call Start: 16:30 January 1, 0000 4:57 PM ET Quantum BioPharma Ltd. (NASDAQ:QNTM ) Business Update Conference Call May 6, 2025, 04:30 PM ET Company Participants Zeeshan Saeed - Founder, Chief Executive Officer, President and Executive Co-Chair Jason Sawyer - Head of Finance and M&A Conference Call Participants Operator Greetings, and welcome to the Quantum BioPharma Business Update Conference Call.

VTEX (NYSE:VTEX ) Q1 2025 Results Conference Call May 6, 2025 4:30 PM ET Company Participants Julia Fernandez - VP of Investor Relations Geraldo Thomaz Jr. - Founder, Co-Chief Executive Officer Ricardo Sodre - Chief Financial Officer Mariano Gomide - Founder, Co-Chief Executive Officer Conference Call Participants Marcelo Santos - JPMorgan Lucca Brendim - Bank of America Leonardo Olmos - UBS Maria Infantozzi - Itau Operator Hello, everyone, and welcome to VTEX's Earnings Conference Call for the First Quarter of 2025. I'm Julia Vater Fernandez, VP of Investor Relations.

SAN DIEGO , May 6, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Civitas Resources, Inc. (NYSE: CIVI) securities between February 27, 2024 and February 24, 2025. Civitas is an independent exploration and production company focused on the acquisition, development and production of crude oil and liquids-rich natural gas from its assets in the Denver-Julesburg ("DJ") Basin in Colorado and the Permian Basin in Texas and New Mexico.

Rivian Automotive, Inc. (NASDAQ:RIVN ) Q1 2025 Earnings Conference Call May 6, 2025 5:00 PM ET Company Participants Derek Mulvey - Vice President of Finance RJ Scaringe - Founder and Chief Executive Officer Claire McDonough - Chief Financial Officer Javier Varela - Chief Operations Officer Conference Call Participants Dan Levy - Barclays Adam Jonas - Morgan Stanley Shreyas Patil - Wolfe Research Joseph Spak - UBS Mark Delaney - Goldman Sachs Philippe Houchois - Jefferies Edison Yu - Deutsche Bank George Gianarikas - Canaccord Genuity Ben Kallo - Baird Ronald Jewsikow - Guggenheim Securities Itay Michaeli - TD Cowen Operator …

Super Micro Computer, Inc. (NASDAQ:SMCI ) Q3 2025 Earnings Conference Call May 6, 2025 5:00 PM ET Company Participants Michael Staiger - VP, IR and Corporate Development Charles Liang - Founder, President, CEO and Chairman David Weigand - SVP and CFO Conference Call Participants Samik Chatterjee - JPMorgan Michael Ng - Goldman Sachs George Wang - Barclays Asiya Merchant - Citigroup Ananda Baruah - Loop Capital Nehal Choski - Northland Jon Tanwanteng - CJS Securities Nicholas Doyle - Needham and Company Mehdi Hosseini - SIG Operator Thank you for standing by. My name is Victoria and I will be your …

Tempus AI, Inc. (NASDAQ:TEM ) Q1 2025 Earnings Conference Call May 6, 2025 4:30 PM ET Company Participants Liz Krutoholow – Vice President-Investor Relations Eric Lefkofsky – Founder and Chief Executive Officer Jim Rogers – Chief Financial Officer Conference Call Participants Tejas Savant – Morgan Stanley Ryan MacDonald – Needham & Company Mark Schappel – Loop Capital Subbu Nambi – Guggenheim Daniel Brennan – TD Cowen Mark Massaro – BTIG Michael Ryskin – Bank of America Rachel Vatnsdal – JPMorgan Dan Arias – Stifel Operator Good day everyone. And thank you for standing by.

Arcus Biosciences, Inc. (NYSE:RCUS ) Q1 2025 Earnings Conference Call May 6, 2025 4:30 PM ET Company Participants Pia Eaves - VP, IR Terry Rosen - CEO Richard Markus - CMO Jennifer Jarrett - COO Bob Goeltz - CFO Juan Jaen - President Conference Call Participants Peter Lawson - Barclays Daina Graybosch - Leerink Partners Yigal Nochomovitz - Citigroup Umer Raffat - Evercore Eva Fortea - Wells Fargo Emily Bodnar - HC Wainwright Operator Hello, everyone. And welcome to Arcus Biosciences First Quarter 2025 Earnings and Financial Results Call.

Investors can contact the law firm at no cost to learn more about recovering their losses

Keros Therapeutics, Inc. (KROS) came out with quarterly earnings of $3.62 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to loss of $1.21 per share a year ago.

Start Time: 17:00 January 1, 0000 5:52 PM ET DoorDash, Inc. (NASDAQ:DASH ) Q1 2025 Earnings Conference Call May 06, 2025, 17:00 PM ET Company Participants Tony Xu - Co-Founder, Chair and CEO Ravi Inukonda - CFO Wes Twigg - IR Conference Call Participants Shweta Khajuria - Wolfe Research Deepak Mathivanan - Cantor Fitzgerald Nikhil Devnani - Bernstein Youssef Squali - Truist Securities Michael Morton - MoffettNathanson Andrew Boone - Citizens Ken Gawrelski - Wells Fargo Doug Anmuth - JPMorgan Mark Mahaney - Evercore Brian Nowak - Morgan Stanley Ron Josey - Citi Mark Zgutowicz - The Benchmark Company John …

Standard BioTools Inc. (NASDAQ:LAB ) Q1 2025 Earnings Conference Call May 6, 2025 4:30 PM ET Company Participants John Graziano - VP of IR Michael Egholm - President & CEO Alex Kim - CFO Conference Call Participants Kyle Boucher - TD Cowen Matt Stanton - Jefferies Paul Knight - KeyBanc Operator Good day and welcome to the Standard BioTools, Inc., First Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded.

The Baldwin Insurance Group, Inc. (NASDAQ:BWIN ) Q1 2025 Earnings Conference Call May 6, 2025 5:00 PM ET Company Participants Trevor Baldwin - CEO Brad Hale - CFO Conference Call Participants Greg Peters - Raymond James Tommy McJoynt - KBW Josh Shanker - Bank of America Elyse Greenspan - Wells Fargo Pablo Singzon - JPMorgan Charlie Lederer - BMO Capital Markets Operator Thank you. Welcome to the Baldwin Group's First Quarter 2025 Earnings Call.

Array Technologies, Inc., founded in 1989, is a leading solar tracking company, primarily serving utility-scale installations, with significant revenue from the US and growing international presence. Recent earnings showed a 97% YoY revenue increase to $302.4 million, beating analyst estimates, but gross margins fell due to low-margin commitments. Management maintained 2025 guidance with revenue of $1.05-1.15 billion and adjusted EPS of 60-70 cents, expecting improved margins in upcoming quarters.

Investors can contact the law firm at no cost to learn more about recovering their losses